Meeting
2013 ASCO Annual Meeting
Effect of capping chemotherapy dose on chemotherapy effect in morbidly obese women with breast cancer.
Authors
David James Porter
Department of Oncology, Auckland City Hospital, Auckland, New Zealand
David James Porter , Michelle Wilson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Cytotoxic Chemotherapy
Citation
J Clin Oncol 31, 2013 (suppl; abstr 1081)
DOI
10.1200/jco.2013.31.15_suppl.1081
Abstract #
1081
Poster Bd #
23H
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Impact of body mass index on treatment and outcomes in patients with early hormone receptor-positive breast cancer receiving endocrine therapy with or without palbociclib in the PALLAS trial.
First Author: Georg Pfeiler
Poster
2018 ASCO Annual Meeting
A longitudinal assessment to evaluate the impact of higher body mass index on cancer-related fatigue in breast cancer patients receiving chemotherapy.
First Author: Julia Ellen Inglis
Poster
2011 ASCO Annual Meeting
Molecular subtypes, body mass index (BMI), and their time-varying prognostic impact in node-positive breast cancer (BC): Pooled analysis from the WSG AM-01 and -02 trials.
First Author: O. Gluz
Poster
2011 ASCO Annual Meeting
Overall survival effect of lower chemotherapy dosing in extremely obese (BMI ≥ 35) patients with breast cancer based on adjusted BSA.
First Author: P. Sharma